Coskun O, Ocakci A, Bayraktaroglu T, Kanter M. (2004). Exercise training prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Tohoku journal of experimental medicine; 203(3): 145-54.
Crampes F, Marion-Latard F, Zakaroff- Girard A, Glisezinski I, Harant I, Thalamas C, et al. (2003). Effects of a longitudinal training program on responses to exercise in overweight men. Obesity research; 11(2):247-56.
Shin-ya Ueda, Hidehiro Nakahara and Tadayoshi Miyamoto. (2013). Effects of exercise on glucagon like peptide-1 (GLP-1). J Phys Fitness Sports Med, 2(2): 221-224.
Gordon BA, Benson AC, Bird SR, Fraser SF. (2009). Resistance training improves metabolic health in type 2 diabetes: a systematic review. Diabetes Res Clin Pract; 83: 157-175.
Teixeira-Lemos E, Nunes S, Teixeira F, Reis F. (2011). Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties. Cardiovasc Diabetol; 10: 1-15.
Näslund E and Hellström PM. (2007). Appetite signaling: from gut peptides and enteric nerves to brain. Physiol Behav 92: 256-262.
Barrera JG, Sandoval DA, DâAlessio DA and Seeley RJ. (2011). GLP-1 and energy balance: an integrated model of short-term and long-term control. Nat Rev Endocrinol 7: 507-516.
Knop FK, Vilsboll T, Holst JJ. (2009). Incretin-based therapy of type 2 diabetes mellitus. Current protein & peptide science; 10(1):46.
Brown J, Dryburgh J, Ross S, Dupre J. (1975). Identification and actions of gastric inhibitory polypeptide. Recent progress in hormone research; 31:487.
Amori RE, Lau J, Pittas AG. (2007). Efficacy and safety of incretin therapy in type 2 diabetes. JAMA: the journal of the American Medical Association; 298(2):194-206.
Meier JJ, Nauck MA, Schmidt WE, Gallwitz B. (2002). Gastric inhibitory polypeptide: the neglected incretin revisited. Regulatory peptides; 107(1-3):1.
Inagaki N, Seino Y, Takeda J, Yano H, Yamada Y, Bell GI, et al. (1989). Gastric inhibitory polypeptide: structure and chromosomal localization of the human gene .Molecular Endocrinology; 3(6):1014-21.
Kreymann B, Ghatei M, Williams G, Bloom S. (1987). Glucagon-like peptide-1 7-36: a physiological incretin in man. The Lancet; 330(8571):1300-4.
Nauck MA, Heimesaat MM, Behle K, Holst JJ, Nauck MS, Ritzel R, et al. (2002). Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. Journal of Clinical Endocrinology & Metabolism; 87(3):1239-46.
Gutzwiller J, Göke B, Drewe J, Hildebrand P, Ketterer S, Handschin D, et al. (1999). Glucagon-like peptide-1: a potent regulator of food intake in humans; 44(1):81-6.
Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, et al. (2011). Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to themetabolic syndrome. Diabetes; 60:1917â25.
Raschke S, Eckardt K, Bjorklund-Holven K, Jensen J, Eckel J. (2013). Identification andvalidation of novel contraction-regulated myokines released from primaryhuman skeletal muscle cells. PLoS.24, 45-9.
Drucker DJ (2007). Dipeptidyl peptidase-4 inhibition and the treatment of type2 diabetes: preclinical biology and mechanisms of action. Diabetes Care; 30:1335â43.
Conarello SL, Li Z, Ronan J, Roy RS, Zhu L, Jiang G, et al. (2003). Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance. Proc Natl AcadSci U S A; 100:6825â30.
Howe SM, Hand TM, Manore MM. (2014). Exercise-Trained Men and Women: Role of Exercise and Diet on Appetite and Energy Intake. Nutrients. 10; 6(11):4935-4960.
Martins C, Kulseng B, King NA, Holst JJ and Blundell JE. (2010). the effects of exercise-induced weight loss on appetite- related peptides and motivation to eat. J Clin Endocrinol Metab 95: 1609-1616.
Reinehr T, Roth CL, Enriori P, Masur K. (2010). Changes of dipeptidyl peptidase IV (DPP-IV) in obese children with weight loss: relationships to peptide YY, pancreatic peptide, and insulin sensitivity. J Pediatr Endocrinol Metab, 23:101â8.
Huda MS, Wilding JP and Pinkney JH. (2006). Gut peptides and the regulation of appetite. Obes Rev 7: 163-182.
Chanoine JP, Mackelvie KJ, Barr SI, Wong AC, Meneilly GS and Elahi DH. (2008). GLP-1 and appetite responses to a meal in lean and overweight adolescents following exercise. Obesity (Silver Spring) 16: 202-204.
Kadoglou N, Vrabas I, Kapelouzou A, Angelopoulou N. (2012). The association of physical activity with novel adipokines in patients with type 2 diabete. European Journal of Internal Medicine. 23: 137-142.
Tang- Christenen M, Vrang N, Larsen PJ. (2001). Glucagons-like peptide containing pathways in the regulation of feeding behavior. Int J Obes Relat Metab Disord; 5: 42-7.
Schick RR, Zimmermann JP, Vorm Wald T. (2002). Glucagons- like peptide-1 (7-36)-amide acts as lateral and medial hypothalamic sites to suppress feeding in rats. Am J Physiol Integr Comp Physiol; 284(6):R1427-35
Howe SM, Hand TM, Manore MM. (2014). Exercise-Trained Men and Women: Role of Exercise and Diet on Appetite and Energy Intake. Nutrients. 10; 6(11):4935-4960.
Ellingsgaard H, Hauselmann I, Schuler B, Habib AM, Baggio LL, Meier DT, et al (2011). Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 17: 1481-1489.
Frosig C, Rose AJ, Treebak JT, Kiens B, Richter EA, Wojtaszewski JF.(2007). Effectsof endurance exercise training on insulin signaling in human skeletal mus-cle: interactions at the level of phosphatidylinositol 3-kinase, Akt, and AS160.Diabetes; 56:2093â102.
Miyazaki M, Kato M, Tanaka K, Tanaka M, Kohjima M, Nakamura K, et al.(2012). Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fattyliver disease and its association with insulin resistance and glucose metabolism.Mol Med Rep; 5:729â33.
Steven K, Malina B, Hazel H, Anny M, Sangeeta R. Kashyapc D, et al. (2013). Lower dipeptidyl peptidase-4 following exercise training plus weightloss is related to increased insulin sensitivity in adults with metabolicsyndrome. Peptides, 47; 142â 147.
Boschmann M, Engeli S, Dobberstein K, Budziarek P, Strauss A, Boehnke J, et al. (2009). Dipeptidyl-peptidase-IV inhibition augments postprandial lipid mobi-lization and oxidation in type 2 diabetic patients. J Clin Endocrinol Metab; 94:846â52.
Solomon TP, Haus JM, Marchetti CM, Stanley WC, Kirwan JP. (2009). Effects of exercisetraining and diet on lipid kinetics during free fatty acid-induced insulin resistance in older obese humans with impaired glucose tolerance. Am J PhysiolEndocrinol Metab; 297:E552â9.
Samuel VT, Shulman GI. (2012). Mechanisms for insulin resistance: common threads and missing links. Cell; 148:852â71.
Fadini GP, Avogaro A. (2011). Cardiovascular effects of DPP-4 inhibition: beyond GLP-1.Vascul Pharmacol; 55:10â6.
Fenicchia LM, Kanaley JA, Azevedo JL Jr, Miller CS, Weinstock RS, Carhart RL, et al. (2004). Influence of resistance exercise training on glucose control in women with type 2 diabetes. Metabolism 53:284 â289.
Sunghwan S, In-Kyong J, Kim M, Yeon S, Sue S, Jae HK. (2011). Effects of Resistance Training and Aerobic Exercise on Insulin Sensitivity in Overweight Korean Adolescents: A Controlled Randomized Trial, Diabetes Metab J; 35(4): 418â426.
Aminot-gilchrist DV, Anderson HD. (2004). Insulin resistance associated cardiovascular disease: potential benefits of CLA. American journal clinic nutration, 1159-1163.
DeFronzo RA, Ferrannini F. (1991). Insulin resistance. A mul tifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. American Diabetes Association, 14:173-194.
)